paperKB
coga / coga-kb
Help
Sign in

Chunk #28 — Results — Prevalence of cannabis use

Source
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.
Embedded
yes

Text

to 7·6)+1·2 (0·3 to 2·1)+23·4% 35 to 442·0 (1·4 to 2·7)3·2 (2·1 to 4·3)+1·2 (0·6 to 1·9)+60·4% 45 to 541·1 (0·8 to 1·4)1·7 (1·0 to 2·4)+0·6 (0·1 to 1·1)+56·9% 55 to 640·4 (0·2 to 0·6)0·7 (0·4 to 1·0)+0·3 (0·1 to 0·6)+82·2%PAST YEAR15 to 645·6 (4·3 to 6·9)6·8 (5·4 to 8·2)+1·3 (0·4 to 2·2)+22·7%By age group 15 to 2413·2 (10·1 to 16·2)15·7 (12·1 to 19·3)+2·7 (0·9 to 4·6)+20·7% 25 to 349·0 (6·8 to 11·2)10·6 (8·3 to 13)+1·9 (0·5 to 3·2)+20·8% 35 to 443·6 (2·7 to 4·6)5·4 (3·9 to 6·8)+1·8 (0·9 to 2·7)+49·6% 45 to 542·0 (1·5 to 2·5)3·1 (2·2 to 3·9)+1·1 (0·5 to 1·6)+53·2% 55 to 640·8 (0·6 to 1·1)1·3 (1 to 1·6)+0·5 (0·1 to 0·9)+62·8%Note. Figures in brackets indicate 95% asymptotic confidence intervals based on standard error of reported survey point estimates, not considering variation around each point estimate.1N=22 out of N=26 countries had survey estimates available in 2010, 2011, or 2012, with the remaining estimates obtained from the years 2013 (N=1), 2014 (N=2), or 2015 (N=1)2N=21 out of N=26 countries had survey estimates available in 2017, 2018, or 2019, with the remaining estimates obtained from 2016 (N=3), 2015 (N=2), or 2013 (N=1)3calculated as the population-weighted absolute/relative difference between earliest